Cleopatra Hospitals Group S.A.E. (EGX:CLHO)
Egypt · Delayed Price · Currency is EGP 16.05
+0.35 (2.23%)
At close: Oct 4, 2026
EGX:CLHO Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 23,264 | 19,133 | 11,636 | 6,822 | 7,685 | 7,784 | |
Market Cap Growth | 43.87% | 64.43% | 70.55% | -11.22% | -1.28% | 2.20% |
Enterprise Value | 27,272 | 22,397 | 13,577 | 7,366 | 7,933 | 7,434 |
Last Close Price | 16.05 | 13.20 | 8.05 | 4.72 | 5.32 | 4.92 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 48.07 | 28.56 | 20.51 | 21.35 | 29.81 | 24.24 |
Forward PE | 25.09 | 23.48 | 16.96 | 15.38 | 17.10 | 16.08 |
PS Ratio | 2.85 | 2.65 | 2.15 | 1.90 | 2.97 | 3.05 |
PB Ratio | 5.46 | 4.74 | 3.66 | 2.79 | 3.79 | 3.12 |
P/TBV Ratio | 6.88 | 5.94 | 4.67 | 3.70 | 5.28 | 3.99 |
P/FCF Ratio | - | - | - | - | 505.76 | 21.27 |
P/OCF Ratio | 11.67 | 10.11 | 7.76 | 12.23 | 17.47 | 12.01 |
PEG Ratio | - | 0.40 | 0.40 | 0.45 | 0.50 | 0.60 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.34 | 3.10 | 2.51 | 2.05 | 3.07 | 2.92 |
EV/EBITDA Ratio | 15.72 | 13.10 | 10.12 | 9.08 | 13.65 | 11.55 |
EV/EBIT Ratio | 20.26 | 15.03 | 11.73 | 11.22 | 17.79 | 14.08 |
EV/FCF Ratio | - | - | - | - | 522.11 | 20.31 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.93 | 0.92 | 0.77 | 0.36 | 0.26 | 0.11 |
Debt / EBITDA Ratio | 2.31 | 2.12 | 1.76 | 1.04 | 0.87 | 0.41 |
Debt / FCF Ratio | - | - | - | - | 34.68 | 0.74 |
Net Debt / Equity Ratio | 0.83 | 0.78 | 0.62 | 0.21 | 0.09 | -0.23 |
Net Debt / EBITDA Ratio | 2.09 | 1.85 | 1.48 | 0.64 | 0.31 | -0.89 |
Net Debt / FCF Ratio | -16.51 | -4.16 | -1.65 | -1.93 | 11.90 | -1.57 |
Asset Turnover | 0.80 | 0.81 | 0.90 | 0.93 | 0.77 | 0.82 |
Inventory Turnover | 13.44 | 14.52 | 11.13 | 11.93 | 21.58 | 27.53 |
Quick Ratio | 0.54 | 0.55 | 0.70 | 0.75 | 0.93 | 2.05 |
Current Ratio | 0.66 | 0.71 | 1.06 | 1.24 | 1.24 | 2.27 |
Return on Equity (ROE) | 20.02% | 26.82% | 29.05% | 21.17% | 15.83% | 17.58% |
Return on Assets (ROA) | 8.19% | 10.45% | 11.97% | 10.59% | 8.32% | 10.61% |
Return on Invested Capital (ROIC) | 12.58% | 17.70% | 21.48% | 19.75% | 17.12% | 22.77% |
Return on Capital Employed (ROCE) | 19.10% | 21.50% | 22.00% | 21.50% | 18.90% | 19.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.10% | 4.31% | 6.22% | 6.13% | 4.24% | 4.98% |
FCF Yield | -0.92% | -3.96% | -10.35% | -3.92% | 0.20% | 4.70% |
Payout Ratio | 22.29% | 17.76% | 15.64% | 15.51% | 20.85% | 12.15% |
Buyback Yield / Dilution | -0.36% | - | - | 4.82% | 5.11% | 0.08% |